Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Garance Kopp"'
Autor:
Mayssam Nehme, Laure Vieux, Delphine S. Courvoisier, Olivia Braillard, Hervé Spechbach, Frederique Jacquerioz, Julien Salamun, Frederic Assal, Frederic Lador, Matteo Coen, Thomas Agoritsas, Jean-Luc Reny, Christophe Graf, Lamyae Benzakour, Riccardo Favale, Paola M. Soccal, Guido Bondolfi, Aglaé Tardin, Dina Zekry, Silvia Stringhini, Stéphanie Baggio, Stéphane Genevay, Kim Lauper, Philippe Meyer, Nana Kwabena Poku, Basile N. Landis, Marwène Grira, José Sandoval, Julien Ehrsam, Simon Regard, Camille Genecand, Garance Kopp, Ivan Guerreiro, Gilles Allali, Pauline Vetter, Laurent Kaiser, François Chappuis, Catherine Chenaud, Idris Guessous
Publikováno v:
Preventive Medicine Reports, Vol 29, Iss , Pp 101899- (2022)
Healthcare workers have potentially been among the most exposed to SARS-CoV-2 infection as well as the deleterious toll of the pandemic. This study has the objective to differentiate the pandemic toll from post-acute sequelae of SARS-CoV-2 infection
Externí odkaz:
https://doaj.org/article/b475074a7aa04b73b53cc8999f3d1a1a
Autor:
Garance Kopp, Anne-Lise Hachulla, Stéphane Noble, Aurélien Bringard, Paola M. Soccal, Maurice Beghetti, Frédéric Lador
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
Intravenous treprostinil administration by an implantable pump is an attractive option for pulmonary arterial hypertension (PAH) treatment and is the subject of recent publications. Short-term studies are promising, but there is still a lack of long-
Externí odkaz:
https://doaj.org/article/6454f07c8b2c4471ac95670e74ae1cf5
Autor:
Viridiana Mazzola, Cereghetti Sara, Garance Kopp, Lamyae Benzakour, Dominique Gex, Guido Bondolfi, Mayssam Nehme, Sigiryia Aebischer Perone, Frédéric Lador, Thomas Agoritsas, Olivia Braillard
Publikováno v:
Journal of Psychiatric Research
Objective Psychiatric impact of COVID-19 is still explored and previous data suggest potential risks of anxiety, depression and PTSD related to COVID-19. We aimed to explore the predictive value of risk factors during hospitalization (T0) for COVID-1
Autor:
Mayssam, Nehme, Olivia, Braillard, François, Chappuis, Delphine S, Courvoisier, Laurent, Kaiser, Paola M, Soccal, Jean-Luc, Reny, Frederic, Assal, Guido, Bondolfi, Aglaé, Tardin, Christophe, Graf, Dina, Zekry, Silvia, Stringhini, Hervé, Spechbach, Frederique, Jacquerioz, Julien, Salamun, Frederic, Lador, Matteo, Coen, Thomas, Agoritsas, Lamyae, Benzakour, Riccardo, Favale, Stéphane, Genevay, Kim, Lauper, Philippe, Meyer, Nana K, Poku, Basile N, Landis, Stéphanie, Baggio, Marwène, Grira, José, Sandoval, Julien, Ehrsam, Simon, Regard, Camille, Genecand, Garance, Kopp, Ivan, Guerreiro, Gilles, Allali, Pauline, Vetter, Idris, Guessous
Publikováno v:
Journal of internal medicine. 292(1)
Persistent symptoms of SARS-CoV-2 are prevalent weeks to months following the infection. To date, it is difficult to disentangle the direct from the indirect effects of SARS-CoV-2, including lockdown, social, and economic factors.The study aims to ch
Autor:
Paola M. Soccal, Ivan Guerreiro, Garance Kopp, Frédéric Lador, Aurélien Bringard, Romain Messe, Timothée Fontolliet
Publikováno v:
Clinical respiratory physiology, exercise and functional imaging.
Publikováno v:
Revue medicale suisse. 15(671)
Overlap syndrome (OVS) is defined by the co-existence of chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA) in a same patient. This condition is associated with increased mortality and a higher risk of respiratory exacerba
Publikováno v:
Revue Médicale Suisse. 15:2087-2089
Autor:
Garance Kopp, Maurice Beghetti, Paola M. Soccal, Anne-Lise Hachulla, Stéphane Noble, Frédéric Lador
Publikováno v:
4.3 Pulmonary Circulation and Pulmonary Vascular Diseases.
Introduction: Prostacyclin is a treatment of pulmonary arterial hypertension (PAH). Due to its longer half-life and thermostability, treprostinil allows the development of implantable devices for its IV administration. This approach is appealing as i
Publikováno v:
Revue medicale suisse. 9(402)
Long-term oral anticoagulation is prescribed to 1% of the population to lower thrombotic risk associated with venous thromboembolic disease (VTD), atrial fibrillation (AF), and cardiac mechanical valve. Annually, 10% of patients with at least one of